Skip to main content
BioVaxys Technology Corp. logo

BioVaxys Technology Corp. — Investor Relations & Filings

Ticker · BIOV ISIN · CA09076M2004 LEI · 894500UD22QWRLZYJ229 CSE Professional, scientific and technical activities
Open in API
Filings indexed 436 across all filing types
Latest filing 2020-06-25 Interim / Quarterly Rep…
Country CA Canada
Listing CSE BIOV

About BioVaxys Technology Corp.

https://biovaxys.com/

BioVaxys Technology Corp. is a clinical-stage biopharmaceutical company specializing in the development and out-licensing of novel immunotherapy assets. The core technology is the proprietary DPX™ platform, a unique lipid-in-oil formulation designed for sustained, targeted immune responses. DPX forces active uptake into immune cells and lymph nodes, avoiding systemic side effects common to conventional delivery methods. The platform is versatile, supporting peptides, proteins, mRNA, and small molecules, and is being applied across oncology, infectious disease, allergy, and autoimmune disorders. The lead clinical asset, Maveropepimut-S (MVP-S), has demonstrated promising Phase 2B results in recurrent ovarian cancer and relapsed/refractory Diffuse Large B-Cell Lymphoma (DLBCL). The company is also integrating Artificial Intelligence to enhance immunotherapeutic discovery.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Management’s Discussion & Analysis For the Six Months Ended April 30, 2020' and contains detailed discussion of the company's financial condition, results of operations, business overview, mineral properties, quarterly financial data, and share data. It references the six-month period ended April 30, 2020, and includes substantive financial data and analysis. The document is not a brief announcement or a certification but a comprehensive management report explaining financial results and business trends for an interim period. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2020
2020-06-25 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CEO of Lions Bay Mining Corp. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended April 30, 2020. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3036 characters, which is relatively short and consistent with a certification letter rather than a full interim report.
2020-06-25 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2, which is a Certification of Interim Filings Venture Issuer Basic Certificate. It is a certification by a company director regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended April 30, 2020. The document does not contain actual financial statements or substantive financial data but is an officer certification related to interim filings. According to the Certification Rule, such certifications should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3021 characters) and it is primarily a certification letter, not the report itself.
2020-06-25 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Financial Statements For the Six Months Ended April 30, 2020' and contains detailed unaudited financial statements including statements of financial position, comprehensive loss, shareholders' equity, cash flows, and notes to the financial statements. It explicitly states it is prepared under IFRS IAS 34 - Interim Financial Reporting, which is the standard for interim reports. The document is about a six-month period, which is shorter than a full fiscal year, and contains substantive financial data and analysis. There is no indication that this is an announcement or a certification; it is the actual interim financial report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2020
2020-06-25 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the execution of a secured lending facility between Lions Bay Mining Corp. and BioVaxys Inc., along with information about BioVaxys' vaccine candidate and preclinical study plans. It contains no financial statements, regulatory filings, or detailed financial data. It is an announcement of a financing arrangement and business update related to capital raising and use of proceeds. There is no indication that this is a full financial report, audit, or earnings release. The content fits best under Capital/Financing Update (CAP) as it discusses a secured lending facility and related business developments.
2020-06-23 English
Other.pdf
Merger & Acquisition Classification · 100% confidence The document is titled 'Share Exchange Agreement' and is a detailed legal contract dated June 2020 between BioVaxys Inc. and Lions Bay Mining Corp. It outlines terms and definitions related to a transaction where the Purchaser acquires all issued and outstanding equity of the Company. The content is a formal agreement for a merger or acquisition transaction, including definitions of terms, conditions, and parties involved. There is no indication that this is a report, announcement of voting results, or regulatory filing. It is a merger-related legal contract, not a proxy statement or solicitation. Therefore, the document fits the category of Merger & Acquisition filings, which include merger communications and agreements.
2020-06-17 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.